Beijing Research Development vs Reconciled Depreciation Analysis

603392 Stock

72.94 0.92 1.28%

Beijing Wantai financial indicator trend analysis is way more than just evaluating Beijing Wantai Biological prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Beijing Wantai Biological is a good investment. Please check the relationship between Beijing Wantai Research Development and its Reconciled Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Beijing Wantai Biological Research Development account and Reconciled Depreciation. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Beijing Wantai's Research Development and Reconciled Depreciation is 0.89. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Beijing Wantai Biological, assuming nothing else is changed. The correlation between historical values of Beijing Wantai's Research Development and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Beijing Wantai Biological are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Research Development i.e., Beijing Wantai's Research Development and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Research Development

Reconciled Depreciation

Most indicators from Beijing Wantai's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Beijing Wantai Biological current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 171.5 M, whereas Selling General Administrative is forecasted to decline to about 1.2 B.

	2021	2022	2023	2024 (projected)
Gross Profit	4.9B	10.0B	4.7B	3.4B
Total Revenue	5.8B	11.2B	5.5B	4.0B

Gross Profit Total Revenue

Beijing Wantai fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Common Stock Shares Outstanding
Total Assets		-0.29	0.88	1.0	-0.68	0.99	1.0	0.97	0.98	0.98	0.71	0.97	0.98	-0.72	0.97	0.71	0.9	0.88	0.88	0.95	1.0	0.72	0.88	0.98	-0.06	0.88
Other Current Liab	-0.29		0.11	-0.34	0.27	-0.4	-0.29	-0.49	-0.17	-0.45	-0.15	-0.38	-0.1	0.76	-0.39	-0.09	-0.1	-0.68	0.1	-0.46	-0.22	-0.51	-0.14	-0.33	0.03	-0.42
Total Current Liabilities	0.88	0.11		0.85	-0.53	0.83	0.89	0.78	0.9	0.8	0.75	0.81	0.95	-0.34	0.78	0.72	0.97	0.61	1.0	0.73	0.9	0.64	0.93	0.87	-0.13	0.81
Total Stockholder Equity	1.0	-0.34	0.85		-0.69	1.0	1.0	0.98	0.98	0.99	0.71	0.98	0.96	-0.75	0.98	0.69	0.89	0.89	0.86	0.97	0.99	0.73	0.87	0.98	-0.05	0.89
Other Liab	-0.68	0.27	-0.53	-0.69		-0.7	-0.66	-0.68	-0.69	-0.67	-0.2	-0.62	-0.6	0.56	-0.77	-0.6	-0.51	-0.67	-0.53	-0.79	-0.68	-0.69	-0.63	-0.61	-0.5	-0.68
Net Tangible Assets	0.99	-0.4	0.83	1.0	-0.7		0.99	0.99	0.97	0.99	0.7	0.98	0.95	-0.78	0.98	0.68	0.87	0.92	0.83	0.97	0.98	0.75	0.85	0.97	-0.04	0.89
Retained Earnings	1.0	-0.29	0.89	1.0	-0.66	0.99		0.97	0.98	0.98	0.73	0.97	0.98	-0.71	0.97	0.71	0.91	0.87	0.89	0.94	1.0	0.71	0.88	0.98	-0.1	0.88
Accounts Payable	0.97	-0.49	0.78	0.98	-0.68	0.99	0.97		0.92	1.0	0.68	0.96	0.91	-0.84	0.96	0.69	0.84	0.96	0.78	0.95	0.95	0.77	0.82	0.98	-0.08	0.88
Cash	0.98	-0.17	0.9	0.98	-0.69	0.97	0.98	0.92		0.93	0.68	0.94	0.97	-0.63	0.97	0.72	0.9	0.79	0.9	0.94	0.99	0.66	0.88	0.94	0.0	0.85
Non Current Assets Total	0.98	-0.45	0.8	0.99	-0.67	0.99	0.98	1.0	0.93		0.71	0.98	0.93	-0.82	0.96	0.67	0.86	0.95	0.81	0.95	0.96	0.77	0.84	0.98	-0.1	0.88
Non Currrent Assets Other	0.71	-0.15	0.75	0.71	-0.2	0.7	0.73	0.68	0.68	0.71		0.78	0.73	-0.37	0.63	0.37	0.83	0.59	0.74	0.59	0.71	0.59	0.77	0.72	-0.34	0.75
Other Assets	0.97	-0.38	0.81	0.98	-0.62	0.98	0.97	0.96	0.94	0.98	0.78		0.93	-0.77	0.95	0.56	0.86	0.91	0.81	0.94	0.96	0.74	0.83	0.95	-0.04	0.87
Net Receivables	0.98	-0.1	0.95	0.96	-0.6	0.95	0.98	0.91	0.97	0.93	0.73	0.93		-0.59	0.91	0.71	0.93	0.78	0.95	0.87	0.98	0.64	0.89	0.97	-0.13	0.82
Good Will	-0.72	0.76	-0.34	-0.75	0.56	-0.78	-0.71	-0.84	-0.63	-0.82	-0.37	-0.77	-0.59		-0.76	-0.37	-0.43	-0.93	-0.34	-0.8	-0.67	-0.56	-0.41	-0.74	0.0	-0.58
Short Term Investments	0.97	-0.39	0.78	0.98	-0.77	0.98	0.97	0.96	0.97	0.96	0.63	0.95	0.91	-0.76		0.68	0.82	0.88	0.79	0.99	0.97	0.74	0.83	0.92	0.09	0.88
Non Current Liabilities Total	0.71	-0.09	0.72	0.69	-0.6	0.68	0.71	0.69	0.72	0.67	0.37	0.56	0.71	-0.37	0.68		0.71	0.54	0.74	0.64	0.72	0.5	0.69	0.72	-0.04	0.65
Inventory	0.9	-0.1	0.97	0.89	-0.51	0.87	0.91	0.84	0.9	0.86	0.83	0.86	0.93	-0.43	0.82	0.71		0.7	0.97	0.77	0.91	0.75	0.97	0.91	-0.2	0.91
Other Current Assets	0.88	-0.68	0.61	0.89	-0.67	0.92	0.87	0.96	0.79	0.95	0.59	0.91	0.78	-0.93	0.88	0.54	0.7		0.61	0.9	0.84	0.8	0.71	0.9	-0.03	0.83
Total Liab	0.88	0.1	1.0	0.86	-0.53	0.83	0.89	0.78	0.9	0.81	0.74	0.81	0.95	-0.34	0.79	0.74	0.97	0.61		0.73	0.9	0.64	0.93	0.88	-0.12	0.81
Deferred Long Term Liab	0.95	-0.46	0.73	0.97	-0.79	0.97	0.94	0.95	0.94	0.95	0.59	0.94	0.87	-0.8	0.99	0.64	0.77	0.9	0.73		0.94	0.75	0.8	0.9	0.15	0.87
Total Current Assets	1.0	-0.22	0.9	0.99	-0.68	0.98	1.0	0.95	0.99	0.96	0.71	0.96	0.98	-0.67	0.97	0.72	0.91	0.84	0.9	0.94		0.69	0.88	0.97	-0.05	0.86
Intangible Assets	0.72	-0.51	0.64	0.73	-0.69	0.75	0.71	0.77	0.66	0.77	0.59	0.74	0.64	-0.56	0.74	0.5	0.75	0.8	0.64	0.75	0.69		0.85	0.72	0.19	0.93
Common Stock	0.88	-0.14	0.93	0.87	-0.63	0.85	0.88	0.82	0.88	0.84	0.77	0.83	0.89	-0.41	0.83	0.69	0.97	0.71	0.93	0.8	0.88	0.85		0.86	-0.02	0.95
Property Plant Equipment	0.98	-0.33	0.87	0.98	-0.61	0.97	0.98	0.98	0.94	0.98	0.72	0.95	0.97	-0.74	0.92	0.72	0.91	0.9	0.88	0.9	0.97	0.72	0.86		-0.19	0.86
Long Term Debt	-0.06	0.03	-0.13	-0.05	-0.5	-0.04	-0.1	-0.08	0.0	-0.1	-0.34	-0.04	-0.13	0.0	0.09	-0.04	-0.2	-0.03	-0.12	0.15	-0.05	0.19	-0.02	-0.19		0.02
Common Stock Shares Outstanding	0.88	-0.42	0.81	0.89	-0.68	0.89	0.88	0.88	0.85	0.88	0.75	0.87	0.82	-0.58	0.88	0.65	0.91	0.83	0.81	0.87	0.86	0.93	0.95	0.86	0.02

Click cells to compare fundamentals

Beijing Wantai Account Relationship Matchups

Beijing Wantai fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.2B	3.5B	7.0B	16.2B	15.7B	16.5B
Other Current Liab	259.3M	203.3M	421.5M	480.6M	3.8M	3.6M
Total Current Liabilities	492.0M	829.0M	2.4B	3.5B	2.7B	1.5B
Total Stockholder Equity	1.6B	2.6B	4.5B	12.3B	12.7B	13.3B
Other Liab	71.2M	94.3M	80.2M	58.5M	52.7M	59.9M
Net Tangible Assets	1.3B	2.3B	4.2B	12.0B	13.8B	14.5B
Retained Earnings	996.8M	1.7B	3.4B	7.9B	7.6B	8.0B
Accounts Payable	85.0M	107.3M	154.1M	275.5M	389.6M	409.1M
Cash	283.6M	710.7M	1.4B	5.2B	3.8B	4.0B
Non Current Assets Total	1.3B	1.5B	2.4B	4.0B	5.4B	5.7B
Non Currrent Assets Other	263.5M	412.7M	299.1M	372.3M	459.4M	266.7M
Other Assets	190.4M	297.0M	337.6M	602.9M	693.4M	728.1M
Net Receivables	264.0M	691.3M	2.3B	3.9B	3.0B	3.1B
Short Term Investments	58.0M	50.4M	40.4M	2.0B	2.1B	2.2B
Non Current Liabilities Total	92.2M	94.3M	117.7M	179.4M	161.4M	138.1M
Inventory	236.4M	400.0M	593.2M	869.1M	905.5M	488.6M
Other Current Assets	38.0M	39.5M	105.2M	139.4M	495.1M	519.9M
Total Liab	584.2M	923.3M	2.5B	3.7B	2.8B	1.7B
Deferred Long Term Liab	27.0M	27.8M	19.6M	164.6M	189.3M	198.8M
Total Current Assets	885.7M	2.0B	4.6B	12.2B	10.3B	10.8B
Intangible Assets	242.0M	233.9M	295.1M	332.4M	642.7M	345.4M
Property Plant Equipment	627.7M	791.0M	1.7B	2.2B	2.6B	2.7B
Net Invested Capital	1.6B	2.6B	4.7B	12.6B	12.9B	13.5B
Net Working Capital	393.6M	1.1B	2.3B	8.7B	7.6B	8.0B

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Beijing Stock

Balance Sheet is a snapshot of the financial position of Beijing Wantai Biological at a specified time, usually calculated after every quarter, six months, or one year. Beijing Wantai Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Beijing Wantai and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Beijing currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Beijing Research Development vs Reconciled Depreciation Analysis

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Research Development

Reconciled Depreciation

Beijing Wantai fundamental ratios Correlations

Beijing Wantai Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Beijing Wantai fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Beijing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Retained Earnings	+ 1.0	Total Stockholder Equity

Other Current Assets	- 0.93	Good Will
Good Will	- 0.84	Accounts Payable
Good Will	- 0.82	Non Current Assets Total
Deferred Long Term Liab	- 0.8	Good Will
Deferred Long Term Liab	- 0.79	Other Liab
Good Will	- 0.78	Net Tangible Assets